AllianceBernstein’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.38M | Buy |
433,226
+21,350
| +5% | +$293K | ﹤0.01% | 1504 |
|
|
2026
Q1 | $5.19M | Sell |
411,876
-117,970
| -22% | -$1.58M | ﹤0.01% | 1524 |
|
|
2025
Q4 | $6.68M | Buy |
529,846
+217,340
| +70% | +$2.49M | ﹤0.01% | 1405 |
|
|
2025
Q3 | $3.13M | Buy |
312,506
+112,260
| +56% | +$1.01M | ﹤0.01% | 1753 |
|
|
2025
Q2 | $1.62M | Hold |
200,246
| – | – | ﹤0.01% | 2039 |
|
|
2025
Q1 | $1.68M | Hold |
200,246
| – | – | ﹤0.01% | 1994 |
|
|
2024
Q4 | $1.59M | Buy |
200,246
+4,927
| +3% | +$41.3K | ﹤0.01% | 2087 |
|
|
2024
Q3 | $1.63M | Sell |
195,319
-5,000
| -2% | -$39.1K | ﹤0.01% | 2078 |
|
|
2024
Q2 | $1.27M | Buy |
200,319
+30,120
| +18% | +$191K | ﹤0.01% | 2186 |
|
|
2024
Q1 | $1.03M | Buy |
170,199
+13,200
| +8% | +$74.4K | ﹤0.01% | 2251 |
|
|
2023
Q4 | $953K | Sell |
156,999
-8,590
| -5% | -$38.3K | ﹤0.01% | 2292 |
|
|
2023
Q3 | $699K | Sell |
165,589
-9,910
| -6% | -$37K | ﹤0.01% | 2401 |
|
|
2023
Q2 | $544K | Sell |
175,499
-6,450
| -4% | -$13.7K | ﹤0.01% | 2592 |
|
|
2023
Q1 | $253K | Buy |
181,949
+12,200
| +7% | +$24.3K | ﹤0.01% | 2837 |
|
|
2022
Q4 | $338K | Buy |
169,749
+19,900
| +13% | +$44.6K | ﹤0.01% | 2821 |
|
|
2022
Q3 | $303K | Sell |
149,849
-2,600
| -2% | -$7.29K | ﹤0.01% | 2863 |
|
|
2022
Q2 | $485K | Buy |
152,449
+14,800
| +11% | +$53.6K | ﹤0.01% | 2699 |
|
|
2022
Q1 | $574K | Buy |
137,649
+400
| +0.3% | +$1.77K | ﹤0.01% | 2615 |
|
|
2021
Q4 | $657K | Hold |
137,249
| – | – | ﹤0.01% | 2628 |
|
|
2021
Q3 | $733K | Sell |
137,249
-34,490
| -20% | -$174K | ﹤0.01% | 2617 |
|
|
2021
Q2 | $879K | Buy |
171,739
+29,390
| +21% | +$167K | ﹤0.01% | 2592 |
|
|
2021
Q1 | $958K | Sell |
142,349
-34,700
| -20% | -$192K | ﹤0.01% | 2429 |
|
|
2020
Q4 | $809K | Sell |
177,049
-10,500
| -6% | -$46.5K | ﹤0.01% | 2391 |
|
|
2020
Q3 | $728K | Sell |
187,549
-44,400
| -19% | -$190K | ﹤0.01% | 2324 |
|
|
2020
Q2 | $1.1M | Buy |
231,949
+18,400
| +9% | +$75.8K | ﹤0.01% | 2157 |
|
|
2020
Q1 | $743K | Sell |
213,549
-19,700
| -8% | -$83.4K | ﹤0.01% | 2171 |
|
|
2019
Q4 | $1.12M | Buy |
233,249
+7,600
| +3% | +$26.4K | ﹤0.01% | 2238 |
|
|
2019
Q3 | $654K | Buy |
225,649
+85,400
| +61% | +$298K | ﹤0.01% | 2427 |
|
|
2019
Q2 | $1.01M | Buy |
140,249
+14,200
| +11% | +$145K | ﹤0.01% | 2310 |
|
|
2019
Q1 | $1.79M | Hold |
126,049
| – | – | ﹤0.01% | 1955 |
|
|
2018
Q4 | $1.71M | Sell |
126,049
-1,700
| -1% | -$30.6K | ﹤0.01% | 1915 |
|
|
2018
Q3 | $2.83M | Buy |
127,749
+1,300
| +1% | +$27.4K | ﹤0.01% | 1695 |
|
|
2018
Q2 | $2.08M | Buy |
+126,449
| New | +$2.22M | ﹤0.01% | 1890 |
|
Other funds holding AMRX
TGA
RCMNY
AllianceBernstein's AMRX Position: Q2 2026 in Review
AllianceBernstein increased its Amneal Pharmaceuticals (AMRX) stake by 5.2% in Q2 2026, buying an estimated $293K and bringing the position to 433,226 shares worth $5.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1504.
AllianceBernstein first reported a position in AMRX in Q2 2018 and has held it in 33 quarters since. The position peaked at $6.68M in Q4 2025. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.
- AllianceBernstein held 433,226 shares of Amneal Pharmaceuticals worth $5.38M as of Q2 2026.
- AllianceBernstein bought 21,350 Amneal Pharmaceuticals shares in Q2 2026, an estimated $293K.
- Amneal Pharmaceuticals made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1504 holding.
- AllianceBernstein first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
- AllianceBernstein's Amneal Pharmaceuticals position peaked at $6.68M in Q4 2025.
- 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.